Moderna (MRNA) PT Lowered to $140 at JPMorgan
Tweet
Share
E-mailGet Alerts MRNA Hot Sheet
Price: $158.83 --0%
Rating Summary:
6 Buy, 22 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 15 | New: 10
Rating Summary:
6 Buy, 22 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 15 | New: 10
Join SI Premium – FREE
JPMorgan analyst Jessica Fye lowered the price target on Moderna (NASDAQ: MRNA) to $140.00 (from $145.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Wolfe Research Upgrades Moderna (MRNA) to Peerperform
- Kanzhun Ltd. (BZ) PT Raised to $19 at Bernstein SocGen Group
- Jazz Pharmaceuticals (JAZZ) PT Raised to $277 at RBC Capital
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
